MediWound (MDWD) Cost of Revenue (2014 - 2025)

MediWound's Cost of Revenue history runs 12 years deep, the most recent figure standing at $1.6 million for Q4 2025.

• On a quarterly basis, Cost of Revenue fell 67.81% year-over-year to $1.6 million in Q4 2025; TTM through Dec 2025 was $13.7 million, a 22.08% decrease from a year earlier, with the FY2025 full-year figure at $13.7 million, down 22.08% from the prior year.
• Cost of Revenue declined to $1.6 million in Q4 2025 per MDWD's latest filing, from $4.5 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $4.9 million in Q4 2024 and bottomed at $1.6 million in Q4 2025.
• The 5-year median for Cost of Revenue is $3.7 million (2021), against an average of $3.7 million.
• Across the five-year window, Cost of Revenue surged 46.55% in 2024 and sank 67.81% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $3.9 million in 2021, then fell by 12.36% to $3.5 million in 2022, then jumped by 33.5% to $4.6 million in 2023, then climbed by 6.88% to $4.9 million in 2024, then sank by 67.81% to $1.6 million in 2025.
• Per Business Quant, the three latest MDWD Cost of Revenue figures stand at $1.6 million (Q4 2025), $4.5 million (Q3 2025), and $4.4 million (Q2 2025).